Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer expands Singapore nutrition plant

This article was originally published in The Tan Sheet

Executive Summary

Pfizer invests $100 million to expand its Singapore nutrition plant to better serve key markets including China, Indonesia, Malaysia, Pakistan and Vietnam. The investment increased the plant's production capacity by 50 percent and expanded the facility to 91,963 square meters, according to a July 7 announcement. Pfizer added the nutritional business, including infant formulas Promil Gold, SMA and Nursoy, to its portfolio when it acquired Wyeth in October 2009 (1"The Tan Sheet" Oct. 26, 2009). Last May the company said it will stop operating eight other manufacturing sites by 2015 and plans to reduce activities at six others by the end of 2012 (2"The Tan Sheet" May 24, 2010)

You may also be interested in...

Pfizer Exits Eight Manufacturing Sites And Slices Jobs In Six More

Pfizer will stop production of consumer health care products in Virginia and New York while expanding its consumer product operations in Puerto Rico in a realignment of its manufacturing network

Pfizer Plans To Give Diversified Businesses Time To Grow

Pfizer plans to give its consumer products businesses "the opportunity to grow" as it integrates Wyeth into its operations, according to CEO Jeffrey Kindler

Bluebird Expects Three Filings In 2020, But US Zynteglo Submission Pushed Back

A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts